Biogen Idec are a manufacturer of drugs to help with the symptoms of multiple sclerosis. Biogen Idec are currently focusing most of their research on respiratory diseases and congestive heart failure.
Biogen Idec was created in 2003.
Biogen Idec's population is 4,850.
The ticker symbol for Biogen Idec is BIIB and it is traded on the Nasdaq.
The symbol for Biogen Idec Inc. in NASDAQ is: BIIB.
As of July 2014, the market cap for Biogen Idec Inc. (BIIB) is $79,531,175,196.95.
According the the website 'TheStreet' the highest Biotech stock is Amgen Inc with a A+. Some of the other top Biotech stocks include Celgene Corp, Biogen IDEC INC, and United Therapeutics Corp.
According to Med Ad News, a magazine focused on the pharmaceutical business, the bio-tech companies focusing on newer technologies include Roche, Amgen, Gilead Sciences, Biogen Idec, and Celgene.
IDEC Corporation's population is 1,664.
IDEC Corporation was created in 1945.
IDEC Corporation's motto is 'Think Automation and beyond...'.
Hammurabi's Code
biogen